See more : HK Asia Holdings Limited (1723.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Welcia Holdings Co., Ltd. (3141.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Welcia Holdings Co., Ltd., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Odine Solutions Teknoloji Ticaret ve Sanayi AS (ODINE.IS) Income Statement Analysis – Financial Results
- Kinovo plc (KINO.L) Income Statement Analysis – Financial Results
- Delta 9 Cannabis Inc. (DLTNF) Income Statement Analysis – Financial Results
- boohoo group plc (BHHOF) Income Statement Analysis – Financial Results
- Sinopharm Group Co. Ltd. (SHTDF) Income Statement Analysis – Financial Results
Welcia Holdings Co., Ltd. (3141.T)
About Welcia Holdings Co., Ltd.
Welcia Holdings Co., Ltd., together with its subsidiaries, operates a chain of drug stores with dispensing pharmacies in Japan. Its stores primarily sell OTC, healthcare/nursing care, baby, and health food products, as well as dispensing, cosmetics, household goods, food, and other products. The company also offers counseling, late-night, and long-term care services, as well as home-visit bathing and nursing care support services. In addition, it rents and sells welfare equipment; and provides housing services for elderly people. As of February 28, 2022, the company operated 2,468 stores. Welcia Holdings Co., Ltd. was incorporated in 2008 and is headquartered in Tokyo, Japan. Welcia Holdings Co., Ltd. is a subsidiary of Aeon Co., Ltd.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,217.34B | 1,144.28B | 1,025.95B | 949.65B | 868.28B | 779.15B | 695.27B | 623.16B | 528.40B | 380.46B | 334.39B | 293.38B | 270.82B | 238.75B | 198.93B |
Cost of Revenue | 847.23B | 795.02B | 705.00B | 653.61B | 600.83B | 542.49B | 485.32B | 439.35B | 378.49B | 267.20B | 235.33B | 206.92B | 191.58B | 170.55B | 141.77B |
Gross Profit | 370.11B | 349.26B | 320.95B | 296.05B | 267.46B | 236.66B | 209.95B | 183.82B | 149.91B | 113.26B | 99.06B | 86.46B | 79.24B | 68.20B | 57.16B |
Gross Profit Ratio | 30.40% | 30.52% | 31.28% | 31.17% | 30.80% | 30.37% | 30.20% | 29.50% | 28.37% | 29.77% | 29.62% | 29.47% | 29.26% | 28.56% | 28.74% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 296.85B | 22.83B | 20.11B | 19.51B | 16.41B | 13.97B | 11.08B | 8.88B | 6.61B | 77.85B | 8.80B | 8.10B | 7.12B | 6.68B | 5.83B |
Selling & Marketing | 5.96B | 5.08B | 20.60B | 18.74B | 18.41B | 16.23B | 13.86B | 12.56B | 10.98B | 11.56B | 6.81B | 6.11B | 5.27B | 4.81B | 4.22B |
SG&A | 302.80B | 27.91B | 40.71B | 38.25B | 34.83B | 30.20B | 24.94B | 21.44B | 17.59B | 89.41B | 15.61B | 14.20B | 12.39B | 11.48B | 10.05B |
Other Expenses | 24.08B | 275.71B | 237.21B | 214.81B | 194.82B | 2.73B | 2.32B | 1.86B | 1.82B | 0.00 | 1.42B | 988.00M | 735.00M | 681.00M | 574.00M |
Operating Expenses | 326.88B | 303.61B | 277.92B | 253.06B | 229.65B | 207.61B | 181.12B | 159.73B | 131.14B | 100.98B | 86.45B | 61.78B | 55.82B | 49.91B | 42.28B |
Cost & Expenses | 1,174.11B | 1,098.64B | 982.92B | 906.67B | 830.47B | 750.10B | 666.44B | 599.08B | 509.64B | 368.18B | 321.78B | 268.70B | 247.40B | 220.47B | 184.04B |
Interest Income | 15.00M | 4.00M | 5.00M | 5.00M | 17.00M | 23.00M | 17.00M | 25.00M | 17.00M | 112.00M | 6.00M | 7.00M | 7.00M | 36.00M | 111.00M |
Interest Expense | 723.00M | 600.00M | 468.00M | 428.00M | 393.00M | 311.00M | 250.00M | 249.00M | 225.00M | 0.00 | 202.00M | 162.00M | 190.00M | 242.00M | 268.00M |
Depreciation & Amortization | 24.39B | 23.23B | 18.96B | 16.98B | 15.66B | 14.50B | 13.27B | 11.95B | 10.28B | 8.10B | 6.55B | 5.34B | 4.50B | 3.93B | 3.16B |
EBITDA | 65.45B | 68.86B | 61.98B | 59.95B | 53.47B | 43.54B | 42.09B | 36.03B | 29.04B | 21.07B | 18.88B | 17.25B | 13.80B | 11.04B | 7.91B |
EBITDA Ratio | 5.38% | 6.64% | 6.53% | 6.66% | 6.50% | 5.94% | 6.39% | 6.09% | 5.84% | 5.54% | 6.18% | 10.56% | 10.57% | 9.60% | 9.42% |
Operating Income | 43.23B | 45.64B | 43.02B | 42.97B | 37.80B | 29.05B | 28.83B | 24.08B | 18.76B | 12.97B | 12.61B | 11.49B | 10.86B | 7.67B | 5.48B |
Operating Income Ratio | 3.55% | 3.99% | 4.19% | 4.53% | 4.35% | 3.73% | 4.15% | 3.86% | 3.55% | 3.41% | 3.77% | 3.92% | 4.01% | 3.21% | 2.76% |
Total Other Income/Expenses | -2.90B | -1.07B | -608.00M | -1.66B | -1.87B | -534.00M | -2.05B | -894.00M | -2.25B | -799.00M | -476.00M | 265.00M | -1.75B | -805.00M | -1.00B |
Income Before Tax | 40.33B | 44.57B | 42.41B | 41.31B | 35.94B | 28.51B | 26.78B | 23.18B | 16.51B | 12.17B | 12.13B | 11.75B | 9.11B | 6.87B | 4.48B |
Income Before Tax Ratio | 3.31% | 3.89% | 4.13% | 4.35% | 4.14% | 3.66% | 3.85% | 3.72% | 3.12% | 3.20% | 3.63% | 4.01% | 3.36% | 2.88% | 2.25% |
Income Tax Expense | 14.00B | 17.51B | 15.96B | 13.38B | 13.28B | 11.19B | 9.66B | 8.74B | 7.02B | 4.51B | 4.12B | 5.60B | 4.41B | 3.25B | 2.37B |
Net Income | 26.45B | 27.03B | 26.45B | 28.00B | 22.80B | 17.42B | 17.17B | 14.45B | 9.53B | 7.45B | 7.67B | 5.90B | 4.54B | 3.52B | 2.15B |
Net Income Ratio | 2.17% | 2.36% | 2.58% | 2.95% | 2.63% | 2.24% | 2.47% | 2.32% | 1.80% | 1.96% | 2.29% | 2.01% | 1.68% | 1.48% | 1.08% |
EPS | 127.83 | 129.38 | 126.98 | 134.23 | 109.23 | 83.62 | 82.38 | 69.46 | 48.87 | 43.16 | 51.67 | 39.91 | 30.74 | 28.54 | 17.42 |
EPS Diluted | 127.75 | 129.29 | 126.98 | 134.10 | 109.12 | 83.54 | 82.38 | 69.39 | 48.82 | 43.15 | 51.67 | 39.91 | 30.74 | 28.54 | 17.42 |
Weighted Avg Shares Out | 206.92M | 208.92M | 208.32M | 208.60M | 208.75M | 208.35M | 208.12M | 208.04M | 194.98M | 172.72M | 148.43M | 147.81M | 147.82M | 123.48M | 123.64M |
Weighted Avg Shares Out (Dil) | 207.06M | 209.07M | 208.49M | 208.80M | 208.95M | 208.56M | 208.36M | 208.26M | 195.17M | 172.73M | 148.43M | 147.81M | 147.82M | 123.48M | 123.64M |
Source: https://incomestatements.info
Category: Stock Reports